3Jialal I, Devaraj S, Venugopal SK. C-reactive protein: riskmarker or mediator in atherothrombosis [J]. Hypertension,2004,44(1):6-11.
4Muscari C,Grossi L,Giordano E,et al. Evaluation of nitric oxiderelease in the coronary effluent by a novel EPR technique: astudy on isolated rat hearts subjected to cold cardioplegia andreperfusion[J]. Life Sci, 2003,74 ( 1 ) : 109-123.
6Tuzcu A, Bahceci M,Gokalp D, et al. Subclinical hypothyroidismmay be associated with elevated high-sensitive c-reactive protein(low grade inflammation) and fasting hyperinsulinemia [J] .EndocrJ,2005,52(1):89-94.
7Festa A,d'Agostino R Jr, Tracy RP, et al. C reactive protein ismore strongly related to post glucose load glucose than to fastingglucose in non-diabetic subjects; the Insulin ResistanceAtherosclerosis Study[J]. Diabet Med, 2002,19 ( 11 ) : 939-943.
4Hak AE,Pols HA,Visser TJ,et al.Subclinical hypothyroidism is an independent risk factor for atheresclerosis and myocardial infarction in elderly women:the rotterdam study[J].Ann Intern Med,2000,132(4):270-278.
5Jialal I,Devaraj S,Venugopal SK.C-reactive protein:risk marker or mediator in atherothrombosis[J].Hypertension,2004,44(1):6-11.
6Bhogat S,Gaiha M,Sharma VK,et al.A comparative evaluation of C-reactive protein as a short-term prognostic marker in severe unstable angina--a preliminary study[J].J Assoc Physiciars India,2003,51:349-354.
7Muscari C,Grossi L,Giordano E,et al.Evaluation of nitric oxide release in the coronary efluent by a novel EPR technique:a study on isolated rat hearts subjected to cold cardioplegia and reperfusion[J].Life Sci,2003,74(1):109-123.
8Graig FA, Ross G. Serum creatine-phosphokinase in thyroid disease[J]. Metabolism, 1963,12(1) : 57-59.
9Lemar HJ,West SG, Garrett CR, et al. Covert hypothyroidism presenting as a cardiovascular event[J]. Am J Med, 1991,9(5):549-552.
10Madariaga MG,Gamarra N, Dempsey S,et al. Polymyositis-like syndrome in hypothyroidism: review of cases reported over the past twenty-five years[J]. Thyroid, 2002,12 (4) : 331-336.
